— Know what they know.
Not Investment Advice

LNDC NASDAQ

Landec Corporation
1W: -3.0% 1M: +7.1% 3M: -24.2% 1Y: -7.9% 3Y: -19.5% 5Y: -28.5%
$8.76
Last traded 2022-11-14 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $263.6M mcap · 20M float · 0.327% daily turnover
Smart Money Score
Moderate 50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$263.6M
52W Range7.65-12.0389
Volume52,474
Avg Volume64,265
Beta1.10
Dividend—
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOAlbert Bolles
Employees689
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1996-02-16
Websitelandec.com
5201 Great America Pkwy Ste 232
Santa Clara, CA 93455
US
16503061650
About Landec Corporation

Landec Corporation, established in 1986 and headquartered in Santa Maria, California, is a company dedicated to the design, development, production, and global distribution of distinctive health and wellness products within the food and biomaterials industries. Its main operating divisions are Lifecore and Curation Foods. The Lifecore segment manufactures pharmaceutical-grade sodium hyaluronate (HA) in bulk and also formulates and fills syringes and vials for injectable products used in diverse medical treatments and procedures. This segment further provides a comprehensive range of services to its partners, encompassing technological advancements, material component modifications, analytical and formulation development, pilot and stability investigations, process validation, and the production of materials for clinical studies. These services are offered for both HA-based and non-HA-based products that are aseptically formulated and filled. Lifecore's non-HA medical products primarily target the ophthalmic, orthopedic, and other specialized medical markets. The Curation Foods segment focuses on the processing, marketing, and sale of "O" brand olive oils and wine vinegars. It also offers guacamole and avocado food products under the "Yucatan" and "Cabo Fresh" brands, as well as various private labels.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Morberg John D M-Exempt 17,500 — 2024-01-18
Morberg John D F-InKind 6,283 — 2024-01-18
Morberg John D M-Exempt 17,500 — 2024-01-18
Calloway Nathaniel M-Exempt 5,906 — 2024-01-09
Calloway Nathaniel M-Exempt 5,906 — 2024-01-09

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms